Back to top
more

Novan Inc. (NOVN)

(Delayed Data from NSDQ)

$1.57 USD

1.57
10,573,885

-0.20 (-11.30%)

Updated Mar 3, 2021 04:00 PM ET

Pre-Market: $1.56 -0.01 (-0.64%) 8:50 AM ET

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.41%
2Buy17.88%
3Hold9.48%
4Sell5.03%
5Strong Sell1.87%
S&P50010.70%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 23% (196 out of 254)

Industry: Medical - Drugs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Trades from $1

Zacks News

Top Ranked Momentum Stocks to Buy for April 6th

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, April 6th

Top Ranked Momentum Stocks to Buy for April 2nd

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, April 2nd

Top Ranked Momentum Stocks to Buy for March 30th

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, March 30th

Sanghamitra Saha headshot

Buy 5 Top-Ranked Stocks With Rising P/E

Inside the top-ranked stocks that have been exhibiting rising P/E ratios.

Top Ranked Momentum Stocks to Buy for March 11th

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, March 11th

Actinium Treats First Patient in AML Study on Actimab-A Combo

Actinium (ATNM) treats first patient in the third and final cohort of the Actimab-A and CLAG-M combination phase I study to treat relapsed or refractory acute myeloid leukemia.

Pacira's (PCRX) Q4 Earnings Top Estimates, Revenues In Line

Pacira (PCRX) beats earnings estimates in the fourth quarter of 2019. Revenues are in line with estimates.

Company News For Jan 6, 2020

Companies In The News Are: CANF, LW, INCY, NOVN

Analysts Estimate Novan (NOVN) to Report a Decline in Earnings: What to Look Out for

Novan (NOVN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Analysts Estimate Novan (NOVN) to Report a Decline in Earnings: What to Look Out for

Novan (NOVN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Will NOVAN INC (NOVN) Report Negative Q4 Earnings? What You Should Know

NOVAN INC (NOVN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Novan Announces Top-Line Data From Mid-Stage Molluscum Study

Novan's (NOVN) nitric oxide candidate, SB206, demonstrates statistically significant reduction of lesions in patients with molluscum contagiosum.

Novan (NOVN) Reports Q3 Loss, Lags Revenue Estimates

Novan (NOVN) delivered earnings and revenue surprises of 15.63% and -4.00%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

Novan (NOVN) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Novan (NOVN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Sweta Killa headshot

Is WisdomTree International High Dividend Fund (DTH) a Hot ETF Right Now?

Smart Beta ETF report for DTH

Novan Sees Hammer Chart Pattern: Time to Buy?

Novan has been struggling lately, but the selling pressure may be coming to an end soon.